Jefferies Group’s Ionis Pharmaceuticals IONS Stock Holding History

Jefferies Group’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-59,000	Closed	-$2.35M	–	1852
2021 Q2	$2.35M	Sell	59,000 -138,000	-70%	-$5.41M	0.01%	700
2021 Q1	$8.86M	Buy	+197,000	New	+$11M	0.08%	220
2018 Q3	–	Sell	-20,000	Closed	-$833K	–	2566
2018 Q2	$833K	Buy	+20,000	New	+$887K	﹤0.01%	1359
2017 Q2	–	Sell	-5,400	Closed	-$217K	–	2372
2017 Q1	$217K	Sell	5,400 -120,500	-96%	-$5.41M	﹤0.01%	1995
2016 Q4	$6.02M	Sell	125,900 -72,800	-37%	-$2.88M	0.03%	504
2016 Q3	$7.28M	Buy	+198,700	New	+$6.22M	0.04%	412
2016 Q1	–	Sell	-23,000	Closed	-$1.42M	–	2395
2015 Q4	$1.42M	Buy	+23,000	New	+$1.24M	0.01%	1019
2015 Q3	–	Sell	-8,600	Closed	-$495K	–	2641
2015 Q2	$495K	Buy	+8,600	New	+$547K	﹤0.01%	1573
2014 Q3	–	Sell	-16,900	Closed	-$582K	–	2264
2014 Q2	$582K	Hold	16,900	–	–	﹤0.01%	1155
2014 Q1	$730K	Buy	16,900 +8,100	+92%	+$393K	0.01%	1076
2013 Q4	$351K	Buy	+8,800	New	+$314K	﹤0.01%	1306
2013 Q3	–	Sell	-17,900	Closed	-$481K	–	2051
2013 Q2	$481K	Buy	+17,900	New	+$381K	0.01%	1082

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Jefferies Group's IONS Position: Q3 2022 in Review

Jefferies Group opened a new position in Ionis Pharmaceuticals (IONS) in Q3 2022: 105,566 shares worth $4.67M. The stake represents 0.04% of the portfolio and ranks #360 among its holdings. This is a return to the name: Jefferies Group previously reported a position in IONS as recently as Q4 2021.

Jefferies Group first reported a position in IONS in Q2 2013 and has held it in 27 quarters since. 349 funds tracked by Wall St. Rank hold IONS as of Q3 2022.

Jefferies Group held 105,566 shares of Ionis Pharmaceuticals worth $4.67M as of Q3 2022.
Ionis Pharmaceuticals was a new Jefferies Group position in Q3 2022.
Ionis Pharmaceuticals made up 0.04% of Jefferies Group's portfolio in Q3 2022, its #360 holding.
Jefferies Group first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 27 quarters since.
349 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.